Mar 31, 2021

Inter Parfums Q1 2021 Earnings Report

Inter Parfums reported first quarter results with net sales increasing 37% compared to 2020 and 11% ahead of 2019, and EPS up 172% from 2020 and 45% from 2019.

Key Takeaways

Inter Parfums, Inc. reported strong first quarter results, with sales exceeding pre-pandemic levels from 2019. Net sales increased by 37% compared to 2020 and 11% compared to 2019. EPS also saw significant growth, up 172% from 2020 and 45% from 2019. The company is actively pursuing new license agreements to further accelerate growth.

Net sales increased 37% compared to the first quarter of 2020 and 11% ahead of the first quarter of 2019.

EPS increased 172% from 2020 and 45% from 2019.

Business was especially strong in North America and Asia, with sales rising 56% and 34%, respectively.

The company affirmed its 2021 guidance, projecting net sales of approximately $700 million and diluted net income per share of $1.65.

Total Revenue
$199M
Previous year: $145M
+37.1%
EPS
$0.82
Previous year: $0.32
+156.2%
Average Euro Exchange Rate
1.2
Previous year: 1.1
+9.1%
Advertising & Promotion Expense
21%
Previous year: 19.7%
+6.6%
Gross Profit
$125M
Previous year: $89M
+40.7%
Cash and Equivalents
$294M
Previous year: $204M
+44.1%
Free Cash Flow
$31.3M
Previous year: -$26.4M
-218.7%
Total Assets
$888M
Previous year: $781M
+13.6%

Inter Parfums

Inter Parfums

Inter Parfums Revenue by Geographic Location

Forward Guidance

The company affirmed its 2021 guidance, expecting net sales of approximately $700 million and diluted net income per share of $1.65, assuming current average dollar/euro exchange rates and no significant resurgence of the COVID-19 pandemic.

Positive Outlook

  • Net sales of approximately $700 million
  • Diluted net income per share of $1.65
  • Assumes that the average dollar/euro average exchange rate remains at current levels
  • Assumes that there is no significant resurgence of the COVID-19 pandemic
  • Strong first quarter performance

Challenges Ahead

  • Guidance is subject to the average dollar/euro average exchange rate remaining at current levels
  • Guidance is subject to no significant resurgence of the COVID-19 pandemic
  • Uncertainty related to the ongoing COVID-19 pandemic
  • Potential delays in product launches
  • Dependence on key licenses

Revenue & Expenses

Visualization of income flow from segment revenue to net income